SynBioBeta 2026 Speaker

Joy Jiao

OpenAI

Research Lead

Joy leads the life sciences research team at OpenAI. The goal of the team is to accelerate basic research and drug discovery, by operating across the model training stack to improve model capabilities from molecules to organisms. At OpenAI, Joy previously worked on model safety, personalization, search, and representation learning. She holds a PhD in Systems Biology from Harvard, where she studied the in-patient evolution of cancer cells during immunotherapy as well as the evolution of antibiotic resistance.

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor splatter with lime dots
Blue watercolor splatter
var(--variable-xyeEn_rYM)

Reagan

Jarvis

Anocca AB

CEO, Co-founder

var(--variable-xyeEn_rYM)

Alex

Rives

CZI Biohub

Head of Science

var(--variable-xyeEn_rYM)

Karenโ€ฏ

Akinsanya

Schrodinger

President, R&D โ€“ Therapeutics

var(--variable-xyeEn_rYM)

Christopher

Arendt

Takeda

CSO, Head of Research

var(--variable-xyeEn_rYM)

Stef

van Grieken

Cradle

CEO

var(--variable-xyeEn_rYM)

Michael

Koeris

DARPA

Director, BTO

var(--variable-xyeEn_rYM)

Jennifer

Dionne

Pumpkinseed

CEO

var(--variable-xyeEn_rYM)

Daniyal

Hussain

GSK

Exec. Dir., Tech BD

var(--variable-xyeEn_rYM)

Cynthia

Hong

Novartis

Dir., Search & Evaluation

var(--variable-xyeEn_rYM)

Sarah Lynn

Tao

CSL Behring

Sr. Dir., S&E; Ig TA & Tech Lead

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure

SynBioBeta 2027 May 3-6, San Jose, California